Overview
Updated 14 Jul 2026
Mitchell L. Shiffman, MD, is Director, Liver Institute of Virginia (Bon Secours Mercy Health). The public record shows 402 publications with 54,249 citations (h-index 98), centered on Hepatitis C virus research, Liver Disease Diagnosis and Treatment, Hepatitis B Virus Studies. It also documents an investigator role on 10 registered clinical trials, industry payments reported by 32 companies, 3 NIH-funded awards (1991–2010).
- Most recent indexed publication: 2024 · Alimentary pharmacology & therapeutics
- Top research focus: Hepatitis C virus research
- 10 registered trials on ClinicalTrials.gov
- Open Payments reporting from 32 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 2 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 249.
Clinical & industrytrials, payments and federal funding
Public positionssourced statements on record
- Participant
FDA Gastrointestinal Drugs Advisory Committee meeting on obeticholic acid (Ocaliva) for primary biliary cholangitis, September 13
2024provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →fda.gov ↗ - Guest Editor
Clinics in Liver Disease, 2021 Volume 25-4, 'Challenging Issues in the Management of Chronic Hepatitis B Virus'
2021verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →media.mycme.com ↗
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 10 registered studies on ClinicalTrials.gov. The most recent:
- Study to Check the Safety of Fazirsiran and Learn if Fazirsiran Can Help People With Liver Disease and Scarring (Fibrosis) Due to an Abnormal Version of Alpha-1 Antitrypsin Protein
Sponsor: Takeda
InvestigatorPhase 3RecruitingNCT05677971 - A Pilot Study to Treat Patients With Chronic Hepatitis C Virus (HCV) Genotype 1 and End-Stage Renal Disease (ESRD)
Sponsor: Liver Institute of Virginia
InvestigatorPhase 4UnknownNCT01731301 - Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients
Sponsor: Romark Laboratories L.C.
InvestigatorPhase 2CompletedNCT00637923
Industry payments
Updated 14 Jul 2026
32 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Ipsen Biopharmaceuticals, IncProgram year202523 payments$56,587openpaymentsdata.cms.gov ↗
- Novo Nordisk IncProgram year202520 payments$44,635openpaymentsdata.cms.gov ↗
- Gilead Sciences, Inc.Program year202529 payments$26,965openpaymentsdata.cms.gov ↗
NIH funding
Updated 14 Jul 2026
3 NIH research awards on record, funded 1991–2010 per NIH RePORTER. The latest:
- ANCILLARY STUDY TO THE HALT-C ANTI-VIRAL LONG-TERM TREATMENT AGAINST CIRRHOSI
Virginia Commonwealth University
FY2010$1,289M01RR000065 - CLINICAL TRIAL: HEP C ANTIVIRAL LONG-TERM TREATMENT AGAINST CIRRHOSIS (HALT-C)
Virginia Commonwealth University
FY2009$196,411M01RR000065 - ANCILLARY STUDY TO THE HALT-C ANTI-VIRAL LONG-TERM TREATMENT AGAINST CIRRHOSI
Virginia Commonwealth University
FY2009$466M01RR000065
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
- Open-label, clinical trial extension: Two-year safety and efficacy results of seladelpar in patients with primary biliary cholangitis.
Alimentary pharmacology & therapeutics
2024
Most-cited worksby citation count (OpenAlex)
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
5855 Bremo Rd, MOB North, Suite 509, Richmond, VA 23226
Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doctor.webmd.com ↗
- Board Certified
Internal Medicine, American Board of Internal Medicine
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doctor.webmd.com ↗
Editorial & leadership rolesjournal and society appointments
- Director
Liver Institute of Virginia / Liver Institute of Richmond / Liver Institute of Hampton Roads, Bon Secours Mercy Health
2010verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →media.mycme.com ↗ - Professor of Medicine
Eastern Virginia Medical School, Norfolk, VA
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →media.mycme.com ↗
Secondary affiliationsappointments beyond the home institution
- Former Chief
Hepatology Section, and Medical Director, Liver Transplant Program, VCU Medical Center, Richmond, VA
2009verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →media.mycme.com ↗
Media & interviewspress, podcasts and appearances
- ACG 'Video of the Week': Mitchell Shiffman
MD, FACG, on the Impact of Curing HCV, from 2015 ACG Hepatitis School
2015 - HCPLive video interview: 'Mitchell Shiffman
MD: Current Alcohol-Associated Hepatitis Care, Larsucosterol's Potential'
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hcplive.com ↗ - HCPLive video interview: 'Mitchell Shiffman
MD: Phase 2b AHFIRM Data for Larsucosterol in Alcohol-Associated Hepatitis'
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hcplive.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- LinkedIn
linkedin.com/in/mitchell-l-shiffman-446615166
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - LinkedIn
linkedin.com/in/mitchell-shiffman-b5549516
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →linkedin.com ↗
Mentions by otherswhere others cite or feature them
- X / Twitter
aasld.confex.com/aasld/2023/meetingapp.cgi/Person/182692
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →aasld.confex.com ↗ - Other
blog.bonsecours.com/healthy/hepatitis-information-doctor-profile-virginia
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →blog.bonsecours.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this specialty yet.